Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Endocr J ; 67(1): 73-80, 2020 Jan 28.
Artigo em Inglês | MEDLINE | ID: mdl-31611477

RESUMO

Those who smoke nicotine-based cigarettes have elevated plasma levels of ghrelin, a hormone secreted from the stomach. Ghrelin has various physiological functions and has recently been shown to be involved in regulating biological rhythms. Therefore, in this study, in order to clarify the significance of the plasma ghrelin increase in smokers, we sought to clarify how nicotine and ghrelin affect the expression dynamics of clock genes using a mouse model. A single dose of nicotine administered intraperitoneally increased plasma ghrelin concentrations transiently, whereas continuous administration of nicotine with an osmotic minipump did not induce any change in the plasma ghrelin concentration. Single administration of nicotine resulted in a transient increase in ghrelin gene expression in the pancreas but not in the stomach, which is the major producer of ghrelin. In addition, in the pancreas, the expression of clock genes was also increased temporarily. Therefore, in order to clarify the interaction between nicotine-induced ghrelin gene expression and clock gene expression in the pancreas, nicotine was administered to ghrelin gene-deficient mice. Administration of nicotine to ghrelin-gene deficient mice increased clock gene expression in the pancreas. However, upon nicotine administration to mice pretreated with octanoate to upregulate ghrelin activity, expression levels of nicotine-inducible clock genes in the pancreas were virtually the same as those in mice not administered nicotine. Thus, our findings indicate that pancreatic ghrelin may suppress nicotine-induced clock gene expression in the pancreas.


Assuntos
Peptídeos e Proteínas de Sinalização do Ritmo Circadiano/efeitos dos fármacos , Grelina/efeitos dos fármacos , Hipotálamo/efeitos dos fármacos , Nicotina/farmacologia , Agonistas Nicotínicos/farmacologia , Pâncreas/efeitos dos fármacos , RNA Mensageiro/efeitos dos fármacos , Estômago/efeitos dos fármacos , Fatores de Transcrição ARNTL/efeitos dos fármacos , Fatores de Transcrição ARNTL/genética , Animais , Proteínas CLOCK/efeitos dos fármacos , Proteínas CLOCK/genética , Caprilatos/farmacologia , Peptídeos e Proteínas de Sinalização do Ritmo Circadiano/genética , Criptocromos/efeitos dos fármacos , Criptocromos/genética , Mucosa Gástrica/efeitos dos fármacos , Mucosa Gástrica/metabolismo , Regulação da Expressão Gênica , Grelina/genética , Grelina/metabolismo , Transportador de Glucose Tipo 2/efeitos dos fármacos , Transportador de Glucose Tipo 2/genética , Hipotálamo/metabolismo , Camundongos , Nicotina/administração & dosagem , Agonistas Nicotínicos/administração & dosagem , Pâncreas/metabolismo , Proteínas Circadianas Period/efeitos dos fármacos , Proteínas Circadianas Period/genética
2.
Alcohol ; 49(4): 351-7, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25943583

RESUMO

Adverse life events and highly stressful environments have deleterious consequences for mental health. Those environmental factors can potentiate alcohol and drug abuse in vulnerable individuals carrying specific genetic risk factors, hence producing the final risk for alcohol- and substance-use disorders development. The nature of these genes remains to be fully determined, but studies indicate their direct or indirect relation to the stress hypothalamo-pituitary-adrenal (HPA) axis and/or reward systems. Over the past decade, clock genes have been revealed to be key-players in influencing acute and chronic alcohol/drug effects. In parallel, the influence of chronic stress and stressful life events in promoting alcohol and substance use and abuse has been demonstrated. Furthermore, the reciprocal interaction of clock genes with various HPA-axis components, as well as the evidence for an implication of clock genes in stress-induced alcohol abuse, have led to the idea that clock genes, and Period genes in particular, may represent key genetic factors to consider when examining gene × environment interaction in the etiology of addiction. The aim of the present review is to summarize findings linking clock genes, stress, and alcohol and substance abuse, and to propose potential underlying neurobiological mechanisms.


Assuntos
Alcoolismo/metabolismo , Relógios Circadianos/genética , Peptídeos e Proteínas de Sinalização do Ritmo Circadiano/genética , Interação Gene-Ambiente , Sistema Hipotálamo-Hipofisário/metabolismo , Sistema Hipófise-Suprarrenal/metabolismo , Recompensa , Estresse Psicológico/metabolismo , Animais , Depressores do Sistema Nervoso Central/farmacologia , Relógios Circadianos/efeitos dos fármacos , Peptídeos e Proteínas de Sinalização do Ritmo Circadiano/efeitos dos fármacos , Cocaína/farmacologia , Inibidores da Captação de Dopamina/farmacologia , Etanol/farmacologia , Humanos , Sistema Hipotálamo-Hipofisário/efeitos dos fármacos , Nicotina/farmacologia , Agonistas Nicotínicos/farmacologia , Sistema Hipófise-Suprarrenal/efeitos dos fármacos , Transtornos Relacionados ao Uso de Substâncias/metabolismo
3.
Alcohol ; 49(4): 341-9, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25641765

RESUMO

Addiction is a widespread public health issue with social and economic ramifications. Substance abuse disorders are often accompanied by disruptions in circadian rhythms including sleep/wake cycles, which can exacerbate symptoms of addiction and dependence. Additionally, genetic disturbance of circadian molecular mechanisms can predispose some individuals to substance abuse disorders. In this review, we will discuss how circadian genes can regulate midbrain dopaminergic activity and subsequently, drug intake and reward. We will also suggest future directions for research on circadian genes and drugs of abuse.


Assuntos
Alcoolismo/genética , Relógios Circadianos/genética , Peptídeos e Proteínas de Sinalização do Ritmo Circadiano/genética , Ritmo Circadiano/genética , Dopamina/metabolismo , Mesencéfalo/metabolismo , Recompensa , Alcoolismo/metabolismo , Animais , Comportamento Aditivo/genética , Comportamento Aditivo/metabolismo , Depressores do Sistema Nervoso Central/farmacologia , Relógios Circadianos/efeitos dos fármacos , Ritmo Circadiano/efeitos dos fármacos , Peptídeos e Proteínas de Sinalização do Ritmo Circadiano/efeitos dos fármacos , Etanol/farmacologia , Expressão Gênica/efeitos dos fármacos , Humanos , Mesencéfalo/efeitos dos fármacos , Transtornos Relacionados ao Uso de Substâncias/genética , Transtornos Relacionados ao Uso de Substâncias/metabolismo
5.
Alcohol ; 49(4): 389-98, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25499101

RESUMO

The circadian clock establishes rhythms throughout the body with an approximately 24 hour period that affect expression of hundreds of genes. Epidemiological data reveal chronic circadian misalignment, common in our society, significantly increases the risk for a myriad of diseases, including cardiovascular disease, diabetes, cancer, infertility and gastrointestinal disease. Disruption of intestinal barrier function, also known as gut leakiness, is especially important in alcoholic liver disease (ALD). Several studies have shown that alcohol causes ALD in only a 20-30% subset of alcoholics. Thus, a better understanding is needed of why only a subset of alcoholics develops ALD. Compelling evidence shows that increased gut leakiness to microbial products and especially LPS play a critical role in the pathogenesis of ALD. Clock and other circadian clock genes have been shown to regulate lipid transport, motility and other gut functions. We hypothesized that one possible mechanism for alcohol-induced intestinal hyperpermeability is through disruption of central or peripheral (intestinal) circadian regulation. In support of this hypothesis, our recent data shows that disruption of circadian rhythms makes the gut more susceptible to injury. Our in vitro data show that alcohol stimulates increased Clock and Per2 circadian clock proteins and that siRNA knockdown of these proteins prevents alcohol-induced permeability. We also show that intestinal Cyp2e1-mediated oxidative stress is required for alcohol-induced upregulation of Clock and Per2 and intestinal hyperpermeability. Our mouse model of chronic alcohol feeding shows that circadian disruption through genetics (in Clock(▵19) mice) or environmental disruption by weekly 12h phase shifting results in gut leakiness alone and exacerbates alcohol-induced gut leakiness and liver pathology. Our data in human alcoholics show they exhibit abnormal melatonin profiles characteristic of circadian disruption. Taken together our data support circadian mechanisms for alcohol-induced gut leakiness that could provide new therapeutic targets for ALD.


Assuntos
Translocação Bacteriana/genética , Peptídeos e Proteínas de Sinalização do Ritmo Circadiano/genética , Ritmo Circadiano/genética , Mucosa Intestinal/metabolismo , Hepatopatias Alcoólicas/genética , Fígado/metabolismo , Animais , Translocação Bacteriana/efeitos dos fármacos , Depressores do Sistema Nervoso Central/farmacologia , Ritmo Circadiano/efeitos dos fármacos , Peptídeos e Proteínas de Sinalização do Ritmo Circadiano/efeitos dos fármacos , Citocromo P-450 CYP2E1/metabolismo , Modelos Animais de Doenças , Etanol/farmacologia , Humanos , Intestinos/efeitos dos fármacos , Intestinos/microbiologia , Lipopolissacarídeos , Fígado/efeitos dos fármacos , Hepatopatias Alcoólicas/microbiologia , Camundongos , Estresse Oxidativo , Permeabilidade/efeitos dos fármacos
6.
Psychoneuroendocrinology ; 38(11): 2789-99, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24001941

RESUMO

BACKGROUND: Strong links exist between circadian disturbances and some of the most characteristic symptoms of clinical major depressive disorder (MDD). However, changes in the expression of clock genes or neuropeptides related to the regulation of circadian rhythm that may influence the susceptibility to recurrence after antidepressant treatment in MDD have not been investigated. METHODS: Blood samples were collected at 4h intervals for 24h from 12 male healthy controls and 12 male MDD patients before and after treatment with escitalopram for 8 weeks. The outcome measures included the relative expression of clock gene mRNA (PERIOD1, PERIOD2, PERIOD3, CRY1, BMAL1, NPAS2, and GSK-3ß), and the levels of serum melatonin, vasoactive intestinal polypeptide (VIP), cortisol, adrenocorticotropic hormone (ACTH), insulin-like growth factor-1 (IGF-1), and growth hormone (GH). RESULTS: Compared with healthy controls, MDD patients showed disruptions in the diurnal rhythms of the expression of PERIOD1, PERIOD2, CRY1, BMAL1, NPAS2, and GSK-3ß and disruptions in the diurnal rhythms of the release of melatonin, VIP, cortisol, ACTH, IGF-1, and GH. Several of these disruptions (i.e., PER1, CRY1, melatonin, VIP, cortisol, ACTH, and IGF-1) persisted 8 weeks after escitalopram treatment, similar to the increase in the 24h levels of VIP and decreases in the 24h levels of cortisol and ACTH. CONCLUSION: These persistent neurobiological changes may play a role in MDD symptoms that are thought to contribute to the vulnerability to recurrence and long-term maintenance therapy.


Assuntos
Peptídeos e Proteínas de Sinalização do Ritmo Circadiano/genética , Ritmo Circadiano/genética , Citalopram/farmacologia , Transtorno Depressivo Maior/genética , Expressão Gênica/efeitos dos fármacos , Neuropeptídeos/sangue , Hormônio Adrenocorticotrópico/sangue , Adulto , Estudos de Casos e Controles , Ritmo Circadiano/efeitos dos fármacos , Peptídeos e Proteínas de Sinalização do Ritmo Circadiano/efeitos dos fármacos , Citalopram/uso terapêutico , Transtorno Depressivo Maior/sangue , Transtorno Depressivo Maior/tratamento farmacológico , Expressão Gênica/genética , Hormônio do Crescimento/sangue , Humanos , Hidrocortisona/sangue , Fator de Crescimento Insulin-Like I/metabolismo , Masculino , Melatonina/sangue , Avaliação de Sintomas , Peptídeo Intestinal Vasoativo/sangue
7.
PLoS One ; 6(8): e23982, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21887357

RESUMO

Major mood disorders have been linked to abnormalities in circadian rhythms, leading to disturbances in sleep, mood, temperature, and hormonal levels. We provide evidence that ketamine, a drug with rapid antidepressant effects, influences the function of the circadian molecular machinery. Ketamine modulates CLOCK:BMAL1-mediated transcriptional activation when these regulators are ectopically expressed in NG108-15 neuronal cells. Inhibition occurs in a dose-dependent manner and is attenuated after treatment with the GSK3ß antagonist SB21673. We analyzed the effect of ketamine on circadian gene expression and observed a dose-dependent reduction in the amplitude of circadian transcription of the Bmal1, Per2, and Cry1 genes. Finally, chromatin-immunoprecipitation analyses revealed that ketamine altered the recruitment of the CLOCK:BMAL1 complex on circadian promoters in a time-dependent manner. Our results reveal a yet unsuspected molecular mode of action of ketamine and thereby may suggest possible pharmacological antidepressant strategies.


Assuntos
Proteínas CLOCK/fisiologia , Regulação da Expressão Gênica/fisiologia , Ketamina/farmacologia , Poli(ADP-Ribose) Polimerases/fisiologia , Animais , Proteínas CLOCK/efeitos dos fármacos , Peptídeos e Proteínas de Sinalização do Ritmo Circadiano/efeitos dos fármacos , Peptídeos e Proteínas de Sinalização do Ritmo Circadiano/fisiologia , Criptocromos , Antagonistas de Aminoácidos Excitatórios/farmacologia , Camundongos , Proteínas Circadianas Period/genética , Poli(ADP-Ribose) Polimerases/efeitos dos fármacos , Especificidade da Espécie
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA